NCT07391852

Brief Summary

Many young children are exposed to light int he evening hours before bedtime. Children's biological clocks are highly sensitive to evening light exposure, which can delay the timing of the clock and make it harder to fall asleep. The purpose of this study is to test three strategies (adjustment to home lighting, amber-tinted glasses, clear glasses) to reduce evening light exposure in children ages 5-6 years with parent-reported sleep onset difficulties in order to improve their sleep and the timing of their biological clock. This study takes place over approximately 5 weeks. After baseline assessments of children's sleep timing, light exposure, cognition, and circadian rhythms, they will be randomly assigned to one of three interventions to reduce evening light exposure for two weeks. After the two-week intervention period, the baseline measures are repeated and parents are interviewed about their and their child's experiences with the intervention.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
51mo left

Started Jan 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Jan 2026Jul 2030

First Submitted

Initial submission to the registry

January 7, 2026

Completed
8 days until next milestone

Study Start

First participant enrolled

January 15, 2026

Completed
22 days until next milestone

First Posted

Study publicly available on registry

February 6, 2026

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2029

Expected
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2030

Last Updated

February 6, 2026

Status Verified

January 1, 2026

Enrollment Period

3.9 years

First QC Date

January 7, 2026

Last Update Submit

January 29, 2026

Conditions

Keywords

Behavioral sleep problemsCircadian phasesleep onset latencyEarly childhooddim light melatonin onset (DLMO)Evening light exposureLight intervention

Outcome Measures

Primary Outcomes (2)

  • Intervention Feasibility

    Feasibility will be assessed using adherence/compliance rates to assigned intervention protocols.

    Throughout the two-week intervention period.

  • Acceptability

    Acceptability will be assessed using parent-reported qualitative interviews conducted post-intervention.

    Week 5

Secondary Outcomes (4)

  • Circadian Timing

    Assessed once in Week 2 and once in Week 5

  • Sleep Timing

    Throughout the 5 week protocol

  • Light Exposure

    Throughout the 5 week protocol.

  • Sleep-Related Behaviors

    Assessed once in Week 1 and once in Week 5

Other Outcomes (2)

  • Pupillary Light Response

    Baseline

  • Cognitive Functioning

    Assessed once in Week 1 and once in Week 5

Study Arms (3)

Amber Tinted Glasses

EXPERIMENTAL

Wearing "blue-blocker" glasses (lenses that filter out the blue portion of the visible spectrum) can reduce the melatonin suppression and alertness effects of evening light exposure in both adults and adolescents, as well as advance the timing of the circadian clock and sleep onset, compared with participants wearing placebo lenses. This intervention will examine their efficacy in advancing young children's sleep and circadian timing. Children will be given a pair of glasses (Block Blue Light), with amber-tinted lenses (advertised as blocking 100% of light from 380-550 nm. Children will wear the glasses starting 1 h before parent's selected bedtime each evening across the two-week intervention. Parents will also complete a daily diary detailing when the glasses are worn.

Device: Amber Tinted Glasses

Clear Glasses

SHAM COMPARATOR

The sham comparator consists of the same protocols for the amber-tinted glasses, except that children will wear a pair of glasses with clear lenses (advertised as blocking 50% of light from 400-500 nm), which are significantly less effective at blocking short-wavelength light.

Device: Clear Glasses

Smart Lightbulbs

EXPERIMENTAL

The presence of more blue light in the home is associated with later circadian timing in both school-aged children and adults. This intervention will adjust the evening home lighting environment to be less stimulating to children's circadian clocks. Smart light bulbs (dimmable and color tunable LED bulbs) will be installed in participants' homes light fixtures, or in the child's bedroom, bathroom, as well as areas the child is likely to spend time in after dinner (i.e., living room, playroom). The researchers will program the lights to transition to a lower CCT and dimmer intensity to achieve the recommended evening mEDI of 10 lux starting 1 h before the child's parent-selected bedtime.

Device: Smart Lightbulbs

Interventions

Children will wear amber-tinted glasses in the evening hours before bedtime to reduce exposure to short-wavelength (blue) light. The glasses are intended to reduce circadian disruption associated with evening light exposure.

Amber Tinted Glasses

Children will wear clear glasses in the evening hours before bedtime. This sham intervention controls for wearing glasses without reducing light exposure.

Clear Glasses

Smart light bulbs will be installed in the child's home and programmed to reduce short-wavelength light exposure during evening hours before bedtime.

Smart Lightbulbs

Eligibility Criteria

Age60 Months - 83 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • One adult parent of each participating child will also take part in the study. Parents must be able to provide consent for themselves and their child and to complete the interview at the end of the study.

You may not qualify if:

  • Children are excluded for the following reasons:
  • All sleep disorders as indicated on the telephone screener or by clinical cut-off scores on the Children's Sleep Habits Questionnaire (CSHQ), except for insomnia or DSWPD as features of these disorders are directly targeted by the intervention. Secondary analyses will explore if outcomes differ among participants with or without parent-reported symptoms consistent with these diagnoses.
  • Physical abilities that interfere with assessments (e.g., visual impairment), developmental disabilities (e.g., autism, attention-deficit/hyperactivity disorder (ADHD), pervasive developmental disorder), epilepsy or other neurological disorders, metabolic disorders, medical conditions that commonly require treatments or assessments during the night (e.g., cancer, diabetes, active asthma), current infection or lead poisoning; a head injury involving loss of consciousness in the past 6 months.
  • Current use of medications affecting daytime sleepiness, the circadian system, or light sensitivity.
  • Eye disorders or color blindness (determined with Ishihara Color Vision Test); corrected vision with eyeglasses is permitted.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arizona

Tucson, Arizona, 85724, United States

Location

Related Publications (9)

  • Werner H, Lebourgeois MK, Geiger A, Jenni OG. Assessment of chronotype in four- to eleven-year-old children: reliability and validity of the Children's Chronotype Questionnaire (CCTQ). Chronobiol Int. 2009 Jul;26(5):992-1014. doi: 10.1080/07420520903044505.

    PMID: 19637055BACKGROUND
  • LeBourgeois MK, Harsh JR. Development and psychometric evaluation of the Children's Sleep-Wake Scale<sup/> Sleep Health. 2016 Sep;2(3):198-204. doi: 10.1016/j.sleh.2016.04.001.

    PMID: 28066802BACKGROUND
  • Zerbini G, Kantermann T, Merrow M. Strategies to decrease social jetlag: Reducing evening blue light advances sleep and melatonin. Eur J Neurosci. 2020 Jun;51(12):2355-2366. doi: 10.1111/ejn.14293. Epub 2018 Dec 13.

    PMID: 30506899BACKGROUND
  • van der Lely S, Frey S, Garbazza C, Wirz-Justice A, Jenni OG, Steiner R, Wolf S, Cajochen C, Bromundt V, Schmidt C. Blue blocker glasses as a countermeasure for alerting effects of evening light-emitting diode screen exposure in male teenagers. J Adolesc Health. 2015 Jan;56(1):113-9. doi: 10.1016/j.jadohealth.2014.08.002. Epub 2014 Oct 3.

    PMID: 25287985BACKGROUND
  • Owens JA, Spirito A, McGuinn M. The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. Sleep. 2000 Dec 15;23(8):1043-51.

    PMID: 11145319BACKGROUND
  • Lebourgeois MK, Wright KP Jr, Lebourgeois HB, Jenni OG. Dissonance Between Parent-Selected Bedtimes and Young Children's Circadian Physiology Influences Nighttime Settling Difficulties. Mind Brain Educ. 2013 Dec;7(4):234-242. doi: 10.1111/mbe.12032.

    PMID: 24535929BACKGROUND
  • Hartstein LE, Wong SD, Abbas L, Choubai S, Wilson JN, Jablin T, LeBourgeois MK. Creating the Cave: Conducting Circadian Science in Early Childhood. Clocks Sleep. 2023 Feb 20;5(1):85-93. doi: 10.3390/clockssleep5010009.

    PMID: 36810846BACKGROUND
  • Hartstein LE, Diniz Behn C, Wright KP Jr, Akacem LD, Stowe SR, LeBourgeois MK. Evening Light Intensity and Phase Delay of the Circadian Clock in Early Childhood. J Biol Rhythms. 2023 Feb;38(1):77-86. doi: 10.1177/07487304221134330. Epub 2022 Nov 22.

    PMID: 36415902BACKGROUND
  • Hartstein LE, Behn CD, Akacem LD, Stack N, Wright KP Jr, LeBourgeois MK. High sensitivity of melatonin suppression response to evening light in preschool-aged children. J Pineal Res. 2022 Mar;72(2):e12780. doi: 10.1111/jpi.12780. Epub 2022 Jan 8.

    PMID: 34997782BACKGROUND

Study Officials

  • Lauren E Hartstein, PhD

    University of Arizona

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lauren E Hartstein, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants are blinded to study condition. Research staff are aware of assignment after baseline assessments. Laboratory technicians conducting melatonin assays are blinded to study hypotheses and participant condition.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 7, 2026

First Posted

February 6, 2026

Study Start

January 15, 2026

Primary Completion (Estimated)

December 1, 2029

Study Completion (Estimated)

July 31, 2030

Last Updated

February 6, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

No identifiable data will be shared. Only de-identified study data will be made available for research purposes.

Locations